Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2012 (2012), Article ID 109830, 5 pages
http://dx.doi.org/10.1155/2012/109830
Clinical Study

Blood Rheology and Platelet Function in Untreated Early-Stage Essential Hypertensives Complicated with Metabolic Syndrome

The Second Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan

Received 31 October 2011; Accepted 28 February 2012

Academic Editor: Marcel Lebel

Copyright © 2012 Hiroko Sugimori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. D. O. Lowe, “Blood rheology in arterial disease,” Clinical Science, vol. 71, no. 2, pp. 137–146, 1986. View at Google Scholar · View at Scopus
  2. F. Tomoda, M. Takata, S. Kagitani et al., “Different platelet aggregability during mental stress in two stages of essential hypertension,” American Journal of Hypertension, vol. 12, no. 11, pp. 1063–1070, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Ross, “Atherosclerosis—an inflammatory disease,” New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Bröijersén, F. Karpe, A. Hamsten, A. H. Goodall, and P. Hjemdahl, “Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation,” Atherosclerosis, vol. 137, no. 1, pp. 107–113, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Google Scholar
  6. E. S. Ford, “Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence,” Diabetes Care, vol. 28, no. 7, pp. 1769–1778, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kondo, S. Osugi, K. Shimokata et al., “Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 18, no. 4, pp. 574–580, 2011. View at Publisher · View at Google Scholar
  8. L. Zhang, K. Pu, S. Y. Zhang, and W. Q. Ren, “Blood rheological properties are strongly related to the metabolic syndrome in middle-aged Chinese,” International Journal of Cardiology, vol. 112, no. 2, pp. 229–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Lo Presti, D. Sinagra, M. Montana, A. M. Scarpitta, A. Catania, and G. Caimi, “Haemorheological profile in metabolic syndrome,” Clinical Hemorheology and Microcirculation, vol. 26, no. 4, pp. 241–247, 2002. View at Google Scholar · View at Scopus
  10. J. F. Brun, I. Aloulou, and E. Varlet-Marie, “Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?” Clinical Hemorheology and Microcirculation, vol. 30, no. 3-4, pp. 203–209, 2004. View at Google Scholar · View at Scopus
  11. M. Nieuwdorp, E. S. G. Stroes, J. C. M. Meijers, and H. Büller, “Hypercoagulability in the metabolic syndrome,” Current Opinion in Pharmacology, vol. 5, no. 2, pp. 155–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Bogar, “Hemorheology and hypertension: not “chicken or egg” but two chickens from similar eggs,” Clinical Hemorheology and Microcirculation, vol. 26, no. 2, pp. 81–83, 2002. View at Google Scholar · View at Scopus
  13. R. L. Letcher, S. Chien, T. G. Pickering, and J. H. Laragh, “Elevated blood viscosity in patients with borderline essential hypertension,” Hypertension, vol. 5, no. 5, pp. 757–762, 1983. View at Google Scholar · View at Scopus
  14. C. Stumpf, S. John, J. Jukic et al., “Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension,” Journal of Hypertension, vol. 23, no. 5, pp. 995–1000, 2005. View at Google Scholar · View at Scopus
  15. A. O. Rantala, H. Kauma, M. Lilja, M. J. Savolainen, A. Reunanen, and Y. A. Kesäniemi, “Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects,” Journal of Internal Medicine, vol. 245, no. 2, pp. 163–174, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. “1993 guidelines for the management of mild hypertension. memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee,” Hypertension, vol. 22, no. 3, pp. 392–403, 1993.
  17. “Definition and the diagnostic standard for metabolic syndrome—committee to evaluate diagnostic standards for metabolic syndrome,” Nihon Naika Gakkai Zasshi, vol. 94, no. 4, pp. 794–809, 2005 (Japanese).
  18. K. G. Alberti, P. Zimmet, and J. Shaw, “The metabolic syndrome—a new worldwide definition,” The Lancet, vol. 366, no. 9491, pp. 1059–1062, 2005. View at Google Scholar
  19. J. F. Brun, “Hormones, metabolism and body composition as major determinants of blood rheology: potential pathophysiological meaning,” Clinical Hemorheology and Microcirculation, vol. 26, no. 2, pp. 63–79, 2002. View at Google Scholar · View at Scopus
  20. T. Contreras, A. Vayá, S. Palanca, E. Solá, D. Corella, and J. Aznar, “Influence of plasmatic lipids on the hemorheological profile in healthy adults,” Clinical Hemorheology and Microcirculation, vol. 30, no. 3-4, pp. 423–425, 2004. View at Google Scholar · View at Scopus
  21. S. G. Wannamethee, G. D. O. Lowe, A. G. Shaper, A. Rumley, L. Lennon, and P. H. Whincup, “The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men,” Atherosclerosis, vol. 181, no. 1, pp. 101–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. G. Wannamethee, J. Tchernova, P. Whincup et al., “Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease,” Atherosclerosis, vol. 191, no. 2, pp. 418–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Doffin, R. Perrault, and G. Garnaud, “Blood viscosity measurements in both extensional and shear flow by a falling ball viscometer,” Biorheology, vol. 21, no. 1, pp. 89–93, 1984. View at Google Scholar · View at Scopus
  24. C. Fons, J. F. Brun, I. Supparo, C. Mallard, L. Bardet, and A. Orsetti, “Evaluation of blood viscosity at high shear rate with a falling ball viscometer,” Clinical Hemorheology, vol. 13, no. 5, pp. 651–659, 1993. View at Google Scholar · View at Scopus
  25. D. Quemada, “Rheology of concentrated disperse systems II. A model for non-newtonian shear viscosity in steady flows,” Rheologica Acta, vol. 17, no. 6, pp. 632–642, 1978. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Hu, M. Daleskog, and N. Li, “Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding,” Thrombosis Research, vol. 100, no. 3, pp. 161–166, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Rahmouni and D. A. Morgan, “Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin,” Hypertension, vol. 49, no. 3, pp. 647–652, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. T. Alien and S. M. Patterson, “Hemoconcentration and stress: a review of physiological mechanisms and relevance for cardiovascular disease risk,” Biological Psychology, vol. 41, no. 1, pp. 1–27, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Toth, G. Kesmarky, J. Vekasi et al., “Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment,” Clinical Hemorheology and Microcirculation, vol. 21, no. 3-4, pp. 209–216, 1999. View at Google Scholar · View at Scopus
  30. T. Gomi, T. Ikeda, and F. Ikegami, “Beneficial effect of α-blocker on hemorheology in patients with essential hypertension,” American Journal of Hypertension, vol. 10, no. 8, pp. 886–892, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. J. F. Stoltz, F. Zannad, Y. Kdher et al., “Influence of a calcium antagonist on blood rheology and arterial compliance in hypertension: comparison with a thiazide diuretic,” Clinical Hemorheology and Microcirculation, vol. 21, no. 3-4, pp. 201–208, 1999. View at Google Scholar · View at Scopus